D-0074-2021 Class II Terminated

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0074-2021 was initiated by Zydus Pharmaceuticals (USA) Inc on Oct 27, 2020 and is designated Class II. Reason for recall: Failed Dissolution Specification The recall status is terminated (terminated Dec 20, 2022). Affected quantity: 6,840 units.

Recall details

Product Type
Drugs
Report Date
Nov 11, 2020
Initiation Date
Oct 27, 2020
Termination Date
Dec 20, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6,840 units

Product description

Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-771-77

Reason for recall

Failed Dissolution Specification

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot # M005681, EXP 3/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0074-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0074-2021. Report a data issue: hello@regdatalab.com.